Vita 34 AG Stock
Vita 34 AG Stock
We can see a decrease in the price for Vita 34 AG. Compared to yesterday it has lost -€0.080 (-2.860%).
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Vita 34 AG stock is not clear.
With a target price of 5 € there is a hugely positive potential of 83.82% for Vita 34 AG compared to the current price of 2.72 €.
So far the community has only identified positive things for Vita 34 AG stock. The most positive votes were given for criterium "Market Position".
Pros and Cons of Vita 34 AG in the next few years
Pros
?
B****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vita 34 AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vita 34 AG | -2.860% | -4.762% | -14.634% | -44.554% | -54.098% | -46.565% | -81.994% |
| M1 Kliniken AG | 1.060% | 0.642% | 3.297% | 36.827% | -2.083% | 142.268% | 86.139% |
| Mediclin AG | 7.910% | 10.680% | 14.573% | 50.993% | 27.374% | 53.020% | 12.871% |
| Addus Homecare Corp. | -0.980% | 3.553% | 8.511% | 10.870% | 10.870% | 19.298% | 34.211% |
News
EQS-Adhoc: Management Board of FamiCord AG resolves on intended transfer of stock exchange listing from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange
EQS-Adhoc: Management Board of FamiCord AG resolves on intended transfer of stock exchange listing from the regulated market (Prime Standard) to the Scale segment of the Frankfurt Stock Exchange
EQS-News: FamiCord AG wins ArThec as another customer in its CDMO business area
EQS-News: FamiCord AG wins ArThec as another customer in its CDMO business area
EQS-News: FamiCord AG records weaker start to 2026 financial year as expected amid continued market headwinds while subscription base remains robust
EQS-News: FamiCord AG records weaker start to 2026 financial year as expected amid continued market headwinds while subscription base remains robust